In April 1998 David was diagnosed with Spinocerebellar Ataxia Type 1. He hoped to improve his balance, mobility, coordination and speech - his dream being to be able to play football with his kids. His treatment (umbilical cord stem cells and nerve growth factor) began on March 5th, 2007.
Before the treatment

David had unsteady balance and poor coordination: he could only stand up for a short time without support. He had difficulty in walking, and could not walk up or down stairs without using a handrail. He had a slurred speech when tired. David was able to flex his fingers and grip objects, but he could not hold things steadily.
Videos:
Before 1 Play - Download
Before 2 Play - Download
After the treatment
Balance and coordination improved significantly, allowing him to stand up straight with no support for extended periods. His walk was easier than before, and for the first time in seven years he could walk up and down stairs without a handrail, which he could not do before the treatment. His speech was no longer as slurred as before. David’s grip on objects was steadier: this had a positive effect on writing and allowed him to perform day-to-day tasks which he could not do before treatment, such as tying his laces or drinking a cup of water by himself. As a result of these improvements, David was far more self-dependent than before and his confidence grew.
Videos:

March 7th - Standing Play - Download
March 9th - Stairs Play - Download
March 9th - Balance Play - Download
March 9th - Walking Play - Download
March 13th - Coordination Play - Download
March 14th - Balance Play - Download
March 15th - Stairs Play - Download
March 21st - Balance Play - Download
March 23rd - Stairs Play - Download
April 2nd - Coordination Play - Download
April 3rd - Stairs Play - Download
April 3rd - Walking Play - Download
Interviews with David and his wife Karen, recorded after the treatment:
About the improvements:
David Play - Download
Karen 1 Play - Download
Karen 2 Play - Download
About the hospital:
David Play - Download




Beike ist ein Betrieb für Biotechnologie und wurde dank einem Grundkapital der Universität von Peking.. 
